These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 2370798)

  • 1. Natural history and selective management of in transit melanoma.
    Wong JH; Cagle LA; Kopald KH; Swisher SG; Morton DL
    J Surg Oncol; 1990 Jul; 44(3):146-50. PubMed ID: 2370798
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumour response after hyperthermic isolated limb perfusion for locally advanced melanoma.
    Paulsen IF; Chakera AH; Drejøe JB; Klyver H; Dahlstrøm K; Oturai PS; Mortensen J; Hesse B; Schmidt G; Drzewiecki K
    Dan Med J; 2014 Jan; 61(1):A4741. PubMed ID: 24393586
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of sentinel lymph node biopsy in patients with local recurrence or in-transit metastasis of melanoma.
    Gipponi M; Solari N; Giovinazzo D; Queirolo P; Bertoglio S; Villa G; Gualco M; Bleidl D; Cafiero F
    Anticancer Res; 2014 Jun; 34(6):3197-203. PubMed ID: 24922694
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapy for unresectable recurrent and in-transit extremity melanoma.
    Gimbel MI; Delman KA; Zager JS
    Cancer Control; 2008 Jul; 15(3):225-32. PubMed ID: 18596674
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term follow-up of 163 consecutive patients treated with isolated limb perfusion for in-transit metastases of malignant melanoma.
    Olofsson R; Mattsson J; Lindnér P
    Int J Hyperthermia; 2013 Sep; 29(6):551-7. PubMed ID: 23865737
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prophylactic hyperthermic limb perfusion in stage I melanoma.
    Krige JE; King HS; Strover RM
    Eur J Surg Oncol; 1988 Aug; 14(4):321-6. PubMed ID: 3044834
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictors and natural history of in-transit melanoma after sentinel lymphadenectomy.
    Pawlik TM; Ross MI; Johnson MM; Schacherer CW; McClain DM; Mansfield PF; Lee JE; Cormier JN; Gershenwald JE
    Ann Surg Oncol; 2005 Aug; 12(8):587-96. PubMed ID: 16021533
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnosis and treatment of in-transit melanoma metastases.
    Testori A; Ribero S; Bataille V
    Eur J Surg Oncol; 2017 Mar; 43(3):544-560. PubMed ID: 27923593
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improved survival of patients with stage II melanoma of the extremity using hyperthermic isolation perfusion with 1-phenylalanine mustard.
    Hartley JW; Fletcher WS
    J Surg Oncol; 1987 Nov; 36(3):170-4. PubMed ID: 3682836
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dermal melanoma: A report on prognosis, outcomes, and the utility of sentinel lymph node biopsy.
    Doepker MP; Thompson ZJ; Harb JN; Messina JL; Puleo CA; Egan KM; Sarnaik AA; Gonzalez RJ; Sondak VK; Zager JS
    J Surg Oncol; 2016 Jan; 113(1):98-102. PubMed ID: 26661407
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regional hyperthermic perfusion with melphalan after surgery for recurrent malignant melanoma of the extremities--long-term follow-up of a randomised trial.
    Olofsson Bagge R; Mattsson J; Hafström L
    Int J Hyperthermia; 2014 Aug; 30(5):295-8. PubMed ID: 25144818
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adjuvant irradiation for axillary metastases from malignant melanoma.
    Ballo MT; Strom EA; Zagars GK; Bedikian AY; Prieto VG; Mansfield PF; Lee JE; Gershenwald JE; Ross MI
    Int J Radiat Oncol Biol Phys; 2002 Mar; 52(4):964-72. PubMed ID: 11958890
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patterns of initial recurrence and prognosis after sentinel lymph node biopsy and selective lymphadenectomy for melanoma.
    Wagner JD; Ranieri J; Evdokimow DZ; Logan T; Chuang TY; Johnson CS; Jung SH; Wenck S; Coleman JJ
    Plast Reconstr Surg; 2003 Aug; 112(2):486-97. PubMed ID: 12900606
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patterns of recurrence following a negative sentinel lymph node biopsy in 243 patients with stage I or II melanoma.
    Gershenwald JE; Colome MI; Lee JE; Mansfield PF; Tseng C; Lee JJ; Balch CM; Ross MI
    J Clin Oncol; 1998 Jun; 16(6):2253-60. PubMed ID: 9626228
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Melanoma: the management of local recurrence and in-transit metastasis.
    Couture J
    Can J Surg; 1982 Nov; 25(6):698-700. PubMed ID: 7139431
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lymph node ratio has impact on relapse and outcome in patients with stage III melanoma.
    Tas F; Erturk K
    Int J Clin Oncol; 2019 Jun; 24(6):721-726. PubMed ID: 30788673
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The European approach to in-transit melanoma lesions.
    Hoekstra HJ
    Int J Hyperthermia; 2008 May; 24(3):227-37. PubMed ID: 18393001
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patterns of recurrence after sentinel lymph node biopsy for cutaneous melanoma.
    Fincher TR; McCarty TM; Fisher TL; Preskitt JT; Lieberman ZH; Stephens JF; O'Brien JC; Kuhn JA
    Am J Surg; 2003 Dec; 186(6):675-81. PubMed ID: 14672778
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcome of patients with melanoma and histologically negative sentinel lymph nodes.
    Gadd MA; Cosimi AB; Yu J; Duncan LM; Yu L; Flotte TJ; Souba WW; Ott MJ; Wong LS; Sober AJ; Mihm MC; Haluska FG; Tanabe KK
    Arch Surg; 1999 Apr; 134(4):381-7. PubMed ID: 10199310
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Do Not Forget About the Importance of Loco-Regional Therapy in Melanoma Management.
    Wuthrick EJ; Chablani P
    Semin Radiat Oncol; 2019 Apr; 29(2):166-170. PubMed ID: 30827455
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.